Updated: EQRx sells itself to another Alexis Borisy company, Revolution Medicines, in all-stock deal – Endpoints News

by

  1. Updated: EQRx sells itself to another Alexis Borisy company, Revolution Medicines, in all-stock deal Endpoints News
  2. Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital GlobeNewswire
  3. EQRx’s low cost drug dream ends in Revolution FierceBiotech
  4. Revolution Medicines to acquire EQRx in deal that will add $1 billion in cash to its balance sheet to fund R&D MarketWatch
  5. Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital – EQ Benzinga
  6. View Full Coverage on Google News

Read original article here

Leave a Comment